0001209191-21-038431.txt : 20210604
0001209191-21-038431.hdr.sgml : 20210604
20210604192026
ACCESSION NUMBER: 0001209191-21-038431
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATOU GARY
CENTRAL INDEX KEY: 0001283535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 21997862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-17
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001283535
PATOU GARY
200 - 3650 GILMORE WAY
BURNABY
A1
V5G 4W8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
2021-03-17
5
L
0
E
100
19.49
A
100
I
See Note
Common Shares
12500
I
See Note
Common Shares
23573
D
Stock Option (Right to Buy)
18.56
2021-06-03
4
A
0
10000
0.00
A
2031-06-02
Common Shares
10000
10000
D
Shares acquired by the reporting person's son sharing the reporting person's household on the date of acquisition. Subsequent to the acquisition of the reported shares, the reporting person's son no longer shares a household with the reporting person and the reporting person no longer has a reportable beneficial interest in such shares. Subsequent ownership reports filed by the reporting person will not report these shares.
By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou.
One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to
the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year
anniversary of the grant date.
/s/ Cassandra Robinson, Attorney-in-fact
2021-06-04